tirzepatide cigna coverage Virginia Weight Loss Treatment Cigna drops coverage of GLP-1

Med., 2025

In addition, the World Health Organization issued a safety alert this summer on the risk of NAION when using semaglutide medicinesOzempic, Rybelsus, and Wegovy. The WHO Advisory Committee on Safety of Medical Products concluded the Risk Management Plan for semaglutide should be revised to include NAION as a potential risk. In response to the research potentially linking semaglutide to NAION, Todd and nearly two dozen other people have filed lawsuits alleging the drug led to their blindness

Engaging in regular physical activity and adhering to a healthy diet can enhance the medications effects, particularly regarding weight loss

In this phase, the dosage may be reduced or the frequency of injections altered to maintain weight loss